They also demonstrated that MG-132 increased dystrophin, α-sarcoglycan, and β-dystroglycan levels in explants from BMD patients, whereas it increased levels of the DAPC in DMD cases. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.